Article in paperJam about drug pricing issue
November 2022 - PaperJam
Luxembourg has always been a good pupil in access to innovative treatments, but things have changed. In recent months, the administrative practice has evolved in a way that is unfavourable to Luxembourg patients, who have to wait longer to have access to medical innovations (Article in French)
Keep up to date with iml.lu
The flash letter informs you regularlay about the news of our sector in Luxembourg, the news of the research in Luxembourg, within our members and finally about the news of the association. Don't waste a minute and subscribe.